Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 199.07

-3.4%

Nov 20 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (10932)	11/10/1997 8:57:00 AM
From: chirodoc	Read Replies (2) of 32384

<<<<< As you know, Targretin is in pivotal US Phase III trials for CTCL, with an NDA slated for next year. Phase II trials for type II diabetes began in Europe last spring. ....as a long term investor i am willing to wait. i am most confident about lgnd due to their rich pipe and realize that no one drug will send this stock or any stock to the moon. .......but i do feel that there are a lot of other good companies that are targeting the diabetes market and do not see targretin as a blockbuster that will slay the competition. i am assuming that it will take its place as ONE OF THE more popular diabetetic treatments. does this assumption seem accurate?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next